---
title: Schedule
---

Invited talks are limited to 30 minutes with 10 minutes for questions. Selected talks will be limited to 12 minutes with 3 minutes for questions.

## Sunday, April 3rd, 2016



<hr />

<h6>Check-In (2:00 - 9:00pm)</h6>
<h6>Dinner (5:30 - 7:00pm)</h6>
<h6>Keynote (7:00 - 8:00pm)</h6>
[http://lahav.med.harvard.edu/](Galit Lahav): "Therapy guided by protein dynamics in single cells"
<h6>Sponsored Mixer (8:30 - 10:30pm)</h6>

## Monday, April 4th, 2016

### Breakfast (7:00 - 8:30pm)

Registration for lunch with the PIs
<h6>Cancer genomics and gene regulation (9:00 - 10:40am)</h6>
<ul>
 	<li><a href="http://compbio.cs.brown.edu/">Ben Raphael</a>: Computational Characterization of Mutational Heterogeneity in Cancer</li>
 	<li>Julia Lima Fleck: "Integrating mutation and gene expression cross-sectional data to infer cancer progression"</li>
 	<li>Jiguang Wang: "Clonal Evolution of Glioblastoma under Therapy"</li>
 	<li>Pau Creixell: "Kinome-wide Decoding of Determinants of Specificity and Network Attacking Mutations Rewiring Cancer Signaling"</li>
 	<li>Kevin Brennan: "DNA methylation subtyping of head and neck squamous cell carcinoma reveals smoking as a determinant of prognosis and embryonic stem cell-like transcriptional identity"</li>
</ul>
<h6>Poster Session 1 (10:45 - 12:00pm)</h6>
With coffee
<h6>Lunch (12:15 - 1:30pm)</h6>
<h6>Tumor Systems Biology I: Migration and Metastasis (1:45 - 3:25pm)</h6>
<ul>
 	<li>Invited Speaker: <a href="http://www.peytonlab.org/">Shelly Peyton</a>: "Synthetic Environments to Predict Metastatic Risk and Drug Response"</li>
 	<li>Pilhwa Lee: "Physical mechanisms of cancer in the transition to metastasis"</li>
 	<li>Annelien Zweemer: "Apoptosis-mediated AXL activation: contribution to metastatic cancers?"</li>
 	<li>Julia Sero: "Multiparametric analysis of YAP/TAZ regulation by focal adhesion signaling"</li>
 	<li>Jorge G.T. Zanudo: "Combinatorial interventions lend insight into the inhibition of TGFß-driven epithelial-mesenchymal transition and the existence of hybrid epithelial-mesenchymal phenotypes"</li>
</ul>
<h6>Translational Systems Biology (3:45 - 5:25pm)</h6>
<ul>
 	<li>Invited Speaker: <a href="http://pharmacy.utah.edu/pharmtox/faculty/bild.htm">Andrea Bild</a>: "Combating Subclonal Evolution of Resistant Cancer Phenotypes"</li>
 	<li>John Shen: "A network of deeply conserved synthetic-lethal interactions for exploration of precision cancer therapy"</li>
 	<li>Wendy Fantl: "Molecular heterogeneity of ovarian cancer revealed by high-dimensional mass cytometric profiling"</li>
 	<li>Jiyang Yu: "Systems biology and functional genomics identifies HDAC6 as a non-oncogene addiction hub for inflammatory breast cancers"</li>
 	<li>Mohammad Esfahani: "Noninvasive Cancer
Classification Using Diverse Genomic Features in Circulating Tumor DNA"</li>
</ul>
<h6>Dinner (5:45 - 7:15pm)</h6>
<h6>AECCSB Business Session  (7:15 - 8:15pm)</h6>
<h6>Mixer (8:30 - 10:30pm)</h6>
<h2>Tuesday, April 5th, 2016</h2>

<hr />

<h6>Breakfast (7:00 - 8:30am)</h6>
<h6>Tumor Systems Biology II: Microenvironment &amp; Immunotherapy (9:00 - 10:40 am)</h6>
<ul>
 	<li>Invited Speaker: <a href="http://yvchen.bol.ucla.edu/">Yvonne Chen</a>: "Engineering Smarter and Stronger T Cells for Cancer Immunotherapy"</li>
 	<li>Molly Carroll: "Decoding the role of macrophages in ovarian cancer metastasis through a novel in vitro model"</li>
 	<li>Kevin Haigis: "In vivo systems analysis of TNF-a responses in the intestinal epithelium"</li>
 	<li>Stacey Finley: "Predictive model of angiogenic factors in breast tumor tissue"</li>
 	<li>Edward Richards: "TAM family RTKs promote the metastatic niche at the tumor-immune interface through suppressing cytokine production in residing immune cell populations"</li>
</ul>
<h6>Poster session 2 (10:45am - 12p)</h6>
With coffee
<h6>Lunch (12:15 -1:30 pm)</h6>
<h6>Systems Pharmacology: Drug Resistance &amp; Combinations (1:45p - 3:25 pm)</h6>
<ul>
 	<li>Invited Speaker: Frank Stegmeier: "Systematic Discovery of Cancer Vulnerabilities"</li>
 	<li>Benedict Anchang: "DRUGNEM: an optimized drug combination strategy using single-cell monotherapy perturbation response that accounts for intratumor heterogeneity"</li>
 	<li>Isaac Harris: "Functional profiling of metabolic liabilities in cancer"</li>
 	<li>Laura Heiser: "A systems biology paradigm to identify therapeutically relevant molecular networks in breast cancer"</li>
 	<li>Adam Palmer: "A curative combination therapy lacks synergy but eradicates drug resistance through independent modes of cell killing"</li>
</ul>
<h6>NCI Session 1 (3:45 - 5:15pm)</h6>
<ul>
 	<li>Invited Speaker: <a href="http://ous-research.no/borresen/">Anne-Lise Børresen-Dale</a>: "Multilevel molecular analyses in breast cancer: gauging inter- and intra-tumor heterogeneity and elucidating its role in treatment response."</li>
 	<li>Invited Speaker: <a href="http://asmlab.org/">Aaron Meyer</a>: "Looking across resistance mechanisms to identify molecular commonalities and precision therapy approaches"</li>
</ul>
<h6>Lobster Dinner (5:30 - 7:00pm)</h6>
<h6>NCI Session 2 (7:15 - 8:45pm)</h6>
<ul>
 	<li>Invited Speaker: <a href="http://www.raghukalluri.com">Raghu Kalluri</a>, University of Texas</li>
 	<li>Invited Speaker: <a href="http://healthsciences.ucsd.edu/som/medicine/research/labs/ideker/Pages/default.aspx">Trey Ideker</a>: "The Cancer Cell Map Initiative"</li>
</ul>
<h2>Wednesday, April 6th, 2016</h2>

<hr />

<h6>Breakfast (7:00 - 8:30 am)</h6>
<h6>Signaling networks in Cancer (9:00 - 10:40 am)</h6>
<ul>
 	<li>Invited Speaker: <a href="http://bme.virginia.edu/janes/index.html">Kevin Janes</a>: "Pharmacologic Versus Genetic Targeting of Signaling Networks"</li>
 	<li>Maximilian Billman: "State-dependent genetic interactions identify switches in signaling networks"</li>
 	<li>Jacob Stewart-Ornstein: "Causes and consequences of p53 signaling dynamics in tissues and tumors"</li>
 	<li>Alexis Barr: "A dynamical framework for the all-or-none G1/S transition"</li>
 	<li>Danica Wiredja: "Integrating phosphoproteomics data for precision medicine: bioinformatics workflows identify cell cycle phosphoprotein dysregulation in KRAS mutated cell lines treated with novel activators of Protein Phosphatase 2A"</li>
</ul>
<h6>Keynote  (11:00 - 12:00pm)</h6>
<a href="http://faculty.mdanderson.org/Gordon_Mills/">Gordon B. Mills</a>: "Systems Approach to Cancer"
